+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score



Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score



Rheumatology 53(7): 1229-1234



The aim of this study was to define improvement thresholds for the Juvenile Arthritis Disease Activity Score (JADAS). Physicians' and parents' judgements on treatment efficacy, the ACR paediatric response measure (PedACR) and JADAS were extracted from BIKER. Patients were categorized by baseline classes in the 10-joint JADAS (JADAS10) as low (5 to <15), moderate (15 to <25) and high (25 to ≤40). Cut-offs for defining improvement following treatment with biologics or MTX were chosen by calculating the interquartile ranges (IQRs) of the judgement groups and considering the accuracy, sensitivity and specificity of the resulting model. Differences in the change of JADAS10 by JIA category were also analysed by analysis of variance (ANOVA). Sensitivity, specificity and accuracy were calculated. A total of 1315 treatment courses were analysed. The ANOVA of the JIA categories showed no significant differences of the mean JADAS10 in all baseline classes and IQRs also showed good overall limits. Therefore all JIA categories were combined for a collective cut-off. Analysis by baseline class revealed clear cut-off points. Improvement could be defined by the minimal decrease in the JADAS10 in baseline class low by 4 (41%), moderate by 10 (53%) and high by 17 (57%). The model shows values for accuracy from 75.6 to 85.5% and comparable values for sensitivity and specificity. Improvement after 3 months can be defined efficiently by the decrease of the JADAS10, depending on the baseline JADAS10 score, which specifies low, moderate or high disease activity. Our model demonstrates clear cut-off values. The JADAS10 may be used in addition to ACR criteria in clinical trials. Also, since the JADAS10 can easily be calculated at each patient visit, it also can be used for clinical decisions.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052470273

Download citation: RISBibTeXText

PMID: 24599918

DOI: 10.1093/rheumatology/ket470


Related references

Fri0345Response to etanercept in juvenile idiopathic arthritis using the continuous measure juvenile arthritis disease activity score Jadas:. Annals of the Rheumatic Diseases 71(Suppl 3): 431.1-431, 2013

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 77(3): 336-342, 2017

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 72(12): 1983-1988, 2014

Thu0310Performance of the juvenile arthritis disease activity score Jadas compared to the acr pediatric measures of response in 1470 juvenile idiopathic arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 260.3-261, 2013

Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis. Rheumatology 53(2): 307-312, 2014

Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis and Rheumatism 64(7): 2366-2374, 2012

Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care and Research 66(11): 1703-1709, 2014

FRI0330Development of cut-off values for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score (JADAS):. Annals of the Rheumatic Diseases 71(Suppl 3): 425.3-426, 2013

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 75(3): 635-636, 2016

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. Annals of the Rheumatic Diseases 73(7): 1380-1383, 2014

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study. Rheumatology 55(4): 615-623, 2016

Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis. Revista Brasileira de Reumatologia 55(1): 31-36, 2017

THU0237Disease Activity in Patients with Juvenile Spondyloarthropathy on anti-TNF Therapy as Measured by The Juvenile Arthritis Disease Activity Score (JADAS)-10 and The Juvenile Spondyloarthritis Disease Activity Index (JSPADA). Annals of the Rheumatic Diseases 75(Suppl 2): 273.3-274, 2016

Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis and Rheumatism 61(5): 658-666, 2009

Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. Arthritis and Rheumatism 59(8): 1120-1127, 2008